BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1329468)

  • 1. First-dose blood pressure response in mild-to-moderate heart failure: a randomized, double-blind study comparing enalapril with lisinopril by 24-hour noninvasive blood pressure monitoring.
    Otterstad JE; Froeland G
    Am J Cardiol; 1992 Oct; 70(10):132C-134C. PubMed ID: 1329468
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the first-dose effect of captopril and lisinopril in heart failure.
    Osterziel KJ; Karr M; Busch C; Dietz R
    Am J Cardiol; 1992 Oct; 70(10):137C-139C. PubMed ID: 1329469
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of treatment with lisinopril versus enalapril for congestive heart failure.
    Zannad F; van den Broek SA; Bory M
    Am J Cardiol; 1992 Oct; 70(10):78C-83C. PubMed ID: 1329478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of captopril and lisinopril on circadian blood pressure rhythm and renal function in mild-to-moderate heart failure.
    Osterziel KJ; Karr M; Lemmer B; Dietz R
    Am J Cardiol; 1992 Oct; 70(10):147C-150C. PubMed ID: 1329473
    [No Abstract]   [Full Text] [Related]  

  • 5. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the acute and chronic antihypertensive effects of lisinopril and enalapril assessed by ambulatory blood pressure monitoring.
    Gourlay S; McNeil J; Forbes A; McGrath B
    Clin Exp Hypertens; 1993 Jan; 15(1):71-89. PubMed ID: 8385525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profiles of single and repeat doses of lisinopril and enalapril in congestive heart failure.
    Johnston D; Duffin D
    Am J Cardiol; 1992 Oct; 70(10):151C-153C. PubMed ID: 1329474
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of the safety and efficacy of ACE inhibitors and their effects on 24-hour electrocardiographic monitoring in the treatment of moderate-to-severe heart failure: an interim analysis.
    Adgey J; Clarke M; Raza A; Meddis D
    Am J Cardiol; 1992 Oct; 70(10):142C-144C. PubMed ID: 1329471
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure.
    Bach R; Zardini P
    Am J Cardiol; 1992 Oct; 70(10):70C-77C. PubMed ID: 1329477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lisinopril versus placebo for congestive heart failure.
    Lewis GR
    Am J Cardiol; 1989 Feb; 63(8):12D-16D. PubMed ID: 2537560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of single doses of lisinopril and enalapril in hypertension.
    Dews I; Wiseman WT; al-Khawaja I; Stephens J; VandenBurg M
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy. The Lisinopril-Digoxin Study Group.
    Herlitz J
    Am J Cardiol; 1992 Oct; 70(10):84C-90C. PubMed ID: 1329479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the treatment of heart failure. Report from international symposia 1991-1992.
    Uhlír O; Cihák R
    Cor Vasa; 1992; 34(2):182-7. PubMed ID: 1338983
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors, left ventricular dysfunction, and early heart failure.
    Cleland JG; Shah D; Krikler S; Frost G; Oakley CM
    Am J Cardiol; 1992 Oct; 70(10):55C-61C. PubMed ID: 1329475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril: dose-peak effect relationship in essential hypertension.
    Cirillo VJ; Gomez HJ; Salonen J; Salonen R; Rissanen V; Bolognese JA; Nyberg R; Kristianson K
    Br J Clin Pharmacol; 1988 May; 25(5):533-8. PubMed ID: 2841960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure management in the 1990s: the role of lisinopril. Introduction.
    Rydén L
    Am J Cardiol; 1992 Oct; 70(10):1C-3C. PubMed ID: 1329463
    [No Abstract]   [Full Text] [Related]  

  • 17. 24-hour activity of lisinopril: clinical advantage in blood pressure control.
    Whelton A
    Cardiology; 1991; 79 Suppl 1():10-5. PubMed ID: 1655261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril for severe congestive heart failure.
    Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemaier T
    Am J Cardiol; 1989 Feb; 63(8):8D-11D. PubMed ID: 2537565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of long-term use of lisinopril for congestive heart failure.
    Moyses C; Higgins TJ
    Am J Cardiol; 1992 Oct; 70(10):91C-97C. PubMed ID: 1329480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisinopril dose-response relationship in essential hypertension.
    Gomez HJ; Cirillo VJ; Sromovsky JA; Otterbein ES; Shaw WC; Rush JE; Chrysant SG; Gradman AH; Leon AS; MacCarthy EP
    Br J Clin Pharmacol; 1989 Oct; 28(4):415-20. PubMed ID: 2556172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.